Swiss pharmaceutical companies are planning massive investments in research and manufacturing in the United States as part of a deal to secure lower tariffs. But this […]
United States President Donald Trump’s planned tariffs on pharmaceuticals have disrupted the industry. Here’s a timeline of developments affecting this sector since he came into office […]
A new deal on digital services trade between Singapore and EFTA states, including Switzerland, seeks to reconcile the need for privacy and security with the desire […]
The US is lowering tariffs on Swiss goods from 39% to 15%. The change also covers refined gold, helping secure an important export market for Swiss […]
